Skip to main content
Top
Gepubliceerd in:

16-08-2022 | Original Paper

Screening for Fragile X Syndrome Among Filipino Children with Autism Spectrum Disorder

Auteurs: Angel Belle C. Dy, Lourdes Bernadette S. Tanchanco, Jenica Clarisse Y. Sy, Myla Dominicina Levantino, Randi J. Hagerman

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 11/2023

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Individuals with autism spectrum disorder present with difficulties in social communication, restricted interests or behaviors and other co-morbidities. About 2 to 10% of cases of autism have a genetic cause, and Fragile X Syndrome (FXS) is reported in 0 to 6.5% of individuals with autism. However, the FXS and premutation prevalence among Filipino children has never been reported. The aim of the study was to establish the presence of FXS or premutation carriers among Filipino children with autism and to describe the phenotypic characteristic of cases identified. Blood was collected from 235 children aged 2–6 years old and diagnosed with autism. Samples were analyzed using PCR methods to amplify CGG repeats in the FMRI gene. The diagnosis of autism was confirmed through the Autism Diagnostic Observation Schedule-2. Additional characteristics were documented from a physical examination, Griffiths Scales of Child Development assessment and a parent-answered questionnaire using the Vineland Adaptive Behavior Scale. Fragile X testing through PCR methods in 235 children with diagnosed autism showed 220 (93.6%) were negative, no full mutations, 1 (0.436%) premutation carrier and 14 (5.95%) cases contained intermediate alleles. The FXS testing was limited to confirmed cases of autism, which is considered a high-risk group and does not provide prevalence for the general Filipino population. Subjects were self-referred or referred by clinicians, which may not represent the Filipino autism population with a bias towards those with means for clinical consultations and ability to travel to the place of testing. Samples were not measured for mosaicism, DNA methylation or AGG interspersion patterns. These may have effects on the CGG repeat expansion and overall presentation of FXS. Findings from a single premutation carrier cannot characterize features distinctly present in Filipinos with the mutation. Nevertheless, these results support the data that the prevalence of FXS in Asian populations may be lower than non-Asian populations. This can contribute to a better understanding of FXS and genetic causes of autism in the Philippines and other Asian populations.
Literatuur
go back to reference Abbeduto, L., Thurman, A. J., McDuffie, A., Klusek, J., Feigles, R. T., Ted Brown, W., et al. (2019). ASD comorbidity in fragile X syndrome: Symptom profile and predictors of symptom severity in adolescent and young adult males. Journal of Autism and Developmental Disorders, 49(3), 960–977.PubMedPubMedCentralCrossRef Abbeduto, L., Thurman, A. J., McDuffie, A., Klusek, J., Feigles, R. T., Ted Brown, W., et al. (2019). ASD comorbidity in fragile X syndrome: Symptom profile and predictors of symptom severity in adolescent and young adult males. Journal of Autism and Developmental Disorders, 49(3), 960–977.PubMedPubMedCentralCrossRef
go back to reference Bagni, C., Tassone, F., Neri, G., & Hagerman, R. (2012). Fragile X syndrome: Causes, diagnosis, mechanisms, and therapeutics. The Journal of Clinical Investigation, 122(12), 4314–4322.PubMedPubMedCentralCrossRef Bagni, C., Tassone, F., Neri, G., & Hagerman, R. (2012). Fragile X syndrome: Causes, diagnosis, mechanisms, and therapeutics. The Journal of Clinical Investigation, 122(12), 4314–4322.PubMedPubMedCentralCrossRef
go back to reference Bailey, D. B., Raspa, M., Olmsted, M., & Holiday, D. B. (2008). Co-occurring conditions associated with FMR1 gene variations: Findings from a national parent survey. American Journal of Medical Genetics. Part A, 146A(16), 2060–2069.PubMedCrossRef Bailey, D. B., Raspa, M., Olmsted, M., & Holiday, D. B. (2008). Co-occurring conditions associated with FMR1 gene variations: Findings from a national parent survey. American Journal of Medical Genetics. Part A, 146A(16), 2060–2069.PubMedCrossRef
go back to reference Balicza, P., Varga, N. Á., Bolgár, B., Pentelényi, K., Bencsik, R., Gál, A., et al. (2019). Comprehensive analysis of rare variants of 101 autism-linked genes in a Hungarian cohort of autism spectrum disorder patients. Frontiers in Genetics, 8(10), 434.CrossRef Balicza, P., Varga, N. Á., Bolgár, B., Pentelényi, K., Bencsik, R., Gál, A., et al. (2019). Comprehensive analysis of rare variants of 101 autism-linked genes in a Hungarian cohort of autism spectrum disorder patients. Frontiers in Genetics, 8(10), 434.CrossRef
go back to reference Belmonte, M. K., & Bourgeron, T. (2006). Fragile X syndrome and autism at the intersection of genetic and neural networks. Nature Neuroscience, 9(10), 1221–1225.PubMedCrossRef Belmonte, M. K., & Bourgeron, T. (2006). Fragile X syndrome and autism at the intersection of genetic and neural networks. Nature Neuroscience, 9(10), 1221–1225.PubMedCrossRef
go back to reference Cai, X., Arif, M., Wan, H., Kornreich, R., & Edelmann, L. J. (2019). Clinical genetic testing for fragile X syndrome by polymerase chain reaction amplification and southern blot analyses. Methods in Molecular Biology Clifton NJ., 1942, 11–27.CrossRef Cai, X., Arif, M., Wan, H., Kornreich, R., & Edelmann, L. J. (2019). Clinical genetic testing for fragile X syndrome by polymerase chain reaction amplification and southern blot analyses. Methods in Molecular Biology Clifton NJ., 1942, 11–27.CrossRef
go back to reference Caravella, K. E., & Roberts, J. E. (2017). Adaptive skill trajectories in infants with fragile X syndrome contrasted to typical controls and infants at high risk for autism. Research in Autism Spectrum Disorder, 40, 1–12.CrossRef Caravella, K. E., & Roberts, J. E. (2017). Adaptive skill trajectories in infants with fragile X syndrome contrasted to typical controls and infants at high risk for autism. Research in Autism Spectrum Disorder, 40, 1–12.CrossRef
go back to reference Chen, L., Hadd, A., Sah, S., Houghton, J. F., Filipovic-Sadic, S., Zhang, W., et al. (2011). High-resolution methylation polymerase chain reaction for fragile X analysis: Evidence for novel FMR1 methylation patterns undetected in Southern blot analyses. Genetics in Medicine, 13(6), 528–538.PubMedPubMedCentralCrossRef Chen, L., Hadd, A., Sah, S., Houghton, J. F., Filipovic-Sadic, S., Zhang, W., et al. (2011). High-resolution methylation polymerase chain reaction for fragile X analysis: Evidence for novel FMR1 methylation patterns undetected in Southern blot analyses. Genetics in Medicine, 13(6), 528–538.PubMedPubMedCentralCrossRef
go back to reference Chen, T. A., Lu, X. F., Che, P. K., & Ho, W. K. (1997). Variation of the CGG repeat in FMR-1 gene in normal and fragile X Chinese subjects. Annals of Clinical Biochemistry, 34(Pt 5), 517–520.PubMedCrossRef Chen, T. A., Lu, X. F., Che, P. K., & Ho, W. K. (1997). Variation of the CGG repeat in FMR-1 gene in normal and fragile X Chinese subjects. Annals of Clinical Biochemistry, 34(Pt 5), 517–520.PubMedCrossRef
go back to reference Cheng, Y. K., Lin, C. S., Kwok, Y. K., Chan, Y. M., Lau, T. K., Leung, T. Y., et al. (2017). Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: Implications for screening and prenatal diagnosis. Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi, 23(2), 110–116.PubMed Cheng, Y. K., Lin, C. S., Kwok, Y. K., Chan, Y. M., Lau, T. K., Leung, T. Y., et al. (2017). Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: Implications for screening and prenatal diagnosis. Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi, 23(2), 110–116.PubMed
go back to reference Chonchaiya, W., Au, J., Schneider, A., Hessl, D., Harris, S. W., Laird, M., et al. (2012). Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Human Genetics, 131(4), 581–589.PubMedCrossRef Chonchaiya, W., Au, J., Schneider, A., Hessl, D., Harris, S. W., Laird, M., et al. (2012). Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Human Genetics, 131(4), 581–589.PubMedCrossRef
go back to reference Coffee, B., Keith, K., Albizua, I., Malone, T., Mowrey, J., Sherman, S. L., et al. (2009). Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. American Journal of Human Genetics, 85(4), 503–514.PubMedPubMedCentralCrossRef Coffee, B., Keith, K., Albizua, I., Malone, T., Mowrey, J., Sherman, S. L., et al. (2009). Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. American Journal of Human Genetics, 85(4), 503–514.PubMedPubMedCentralCrossRef
go back to reference Collins, S. C., Bray, S. M., Suhl, J. A., Cutler, D. J., Coffee, B., Zwick, M. E., et al. (2010). Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males. American Journal of Medical Genetics. Part A, 152A(10), 2512–2520.PubMedPubMedCentralCrossRef Collins, S. C., Bray, S. M., Suhl, J. A., Cutler, D. J., Coffee, B., Zwick, M. E., et al. (2010). Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males. American Journal of Medical Genetics. Part A, 152A(10), 2512–2520.PubMedPubMedCentralCrossRef
go back to reference Ergaz, Z., Weinstein-Fudim, L., & Ornoy, A. (2016). Genetic and non-genetic animal models for autism spectrum disorders (ASD). Reproductive Toxicology, 1(64), 116–140.CrossRef Ergaz, Z., Weinstein-Fudim, L., & Ornoy, A. (2016). Genetic and non-genetic animal models for autism spectrum disorders (ASD). Reproductive Toxicology, 1(64), 116–140.CrossRef
go back to reference Estigarribia, B., Erwick Roberts, J., Sideris, J., & Price, J. (2010). Expressive morphosyntax in boys with Fragile X syndrome with and without autism spectrum disorder. International Journal of Language & Communication Disorders, 23, 1–15. Estigarribia, B., Erwick Roberts, J., Sideris, J., & Price, J. (2010). Expressive morphosyntax in boys with Fragile X syndrome with and without autism spectrum disorder. International Journal of Language & Communication Disorders, 23, 1–15.
go back to reference Farzin, F., Perry, H., Hessl, D., Loesch, D., Cohen, J., Bacalman, S., et al. (2006). Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. Journal of Developmental & Behavioral Pediatrics JDBP, 27(2 Suppl), S137-144.CrossRef Farzin, F., Perry, H., Hessl, D., Loesch, D., Cohen, J., Bacalman, S., et al. (2006). Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. Journal of Developmental & Behavioral Pediatrics JDBP, 27(2 Suppl), S137-144.CrossRef
go back to reference Fernandez-Carvajal, I., Walichiewicz, P., Xiaosen, X., Pan, R., Hagerman, P. J., & Tassone, F. (2009). Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population. The Journal of Molecular Diagnostics, 11(4), 324–329.PubMedPubMedCentralCrossRef Fernandez-Carvajal, I., Walichiewicz, P., Xiaosen, X., Pan, R., Hagerman, P. J., & Tassone, F. (2009). Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population. The Journal of Molecular Diagnostics, 11(4), 324–329.PubMedPubMedCentralCrossRef
go back to reference Filipovic-Sadic, S., Sah, S., Chen, L., Krosting, J., Sekinger, E., Zhang, W., et al. (2010). A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clinical Chemistry, 56(3), 399–408.PubMedPubMedCentralCrossRef Filipovic-Sadic, S., Sah, S., Chen, L., Krosting, J., Sekinger, E., Zhang, W., et al. (2010). A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clinical Chemistry, 56(3), 399–408.PubMedPubMedCentralCrossRef
go back to reference Genereux, D. P., & Laird, C. D. (2013). Why do fragile X carrier frequencies differ between Asian and non-Asian populations? Genes & Genetic Systems, 88(3), 211–224.CrossRef Genereux, D. P., & Laird, C. D. (2013). Why do fragile X carrier frequencies differ between Asian and non-Asian populations? Genes & Genetic Systems, 88(3), 211–224.CrossRef
go back to reference Hadi, P., Haghani, K., Noori-Zadeh, A., & Bakhtiyari, S. (2018). Prevalence of fragile X syndrome among patients with mental retardation in the west of Iran. Frontiers of Biology, 13(6), 464–468.CrossRef Hadi, P., Haghani, K., Noori-Zadeh, A., & Bakhtiyari, S. (2018). Prevalence of fragile X syndrome among patients with mental retardation in the west of Iran. Frontiers of Biology, 13(6), 464–468.CrossRef
go back to reference Hagerman, R. J., & Hendren, R. L. (Eds.). (2014). Treatment of neurodevelopmental disorders: Targeting neurobiological mechanisms. Oxford University Press. Hagerman, R. J., & Hendren, R. L. (Eds.). (2014). Treatment of neurodevelopmental disorders: Targeting neurobiological mechanisms. Oxford University Press.
go back to reference Hagerman, R. J., Protic, D., Rajaratnam, A., Salcedo-Arellano, M. J., Aydin, E. Y., & Schneider, A. (2018). Fragile X-associated neuropsychiatric disorders (FXAND). Front Psychiatry., 9, 564.PubMedPubMedCentralCrossRef Hagerman, R. J., Protic, D., Rajaratnam, A., Salcedo-Arellano, M. J., Aydin, E. Y., & Schneider, A. (2018). Fragile X-associated neuropsychiatric disorders (FXAND). Front Psychiatry., 9, 564.PubMedPubMedCentralCrossRef
go back to reference Hnoonual, A., Jankittunpaiboon, C., & Limprasert, P. (2021). Screening for FMR1 CGG repeat expansion in Thai patients with autism spectrum disorder. BioMed Research International, 8(2021), e4359308. Hnoonual, A., Jankittunpaiboon, C., & Limprasert, P. (2021). Screening for FMR1 CGG repeat expansion in Thai patients with autism spectrum disorder. BioMed Research International, 8(2021), e4359308.
go back to reference Hoffmann, A., Thurman, A. J., Sterling, A., Kover, S. T., Finestack, L., Berry-Kravis, E., et al. (2022). Analysis of a repetitive language coding system: Comparisons between fragile X syndrome, autism, and down syndrome. Brain Sciences, 12(5), 575.PubMedPubMedCentralCrossRef Hoffmann, A., Thurman, A. J., Sterling, A., Kover, S. T., Finestack, L., Berry-Kravis, E., et al. (2022). Analysis of a repetitive language coding system: Comparisons between fragile X syndrome, autism, and down syndrome. Brain Sciences, 12(5), 575.PubMedPubMedCentralCrossRef
go back to reference Hoyos, L. R., & Thakur, M. (2017). Fragile X premutation in women: Recognizing the health challenges beyond primary ovarian insufficiency. Journal of Assisted Reproduction and Genetics, 34(3), 315–323.PubMedCrossRef Hoyos, L. R., & Thakur, M. (2017). Fragile X premutation in women: Recognizing the health challenges beyond primary ovarian insufficiency. Journal of Assisted Reproduction and Genetics, 34(3), 315–323.PubMedCrossRef
go back to reference Hunter, J., Rivero-Arias, O., Angelov, A., Kim, E., Fotheringham, I., & Leal, J. (2014). Epidemiology of fragile X syndrome: A systematic review and meta-analysis. American Journal of Medical Genetics. Part A, 164A(7), 1648–1658.PubMedCrossRef Hunter, J., Rivero-Arias, O., Angelov, A., Kim, E., Fotheringham, I., & Leal, J. (2014). Epidemiology of fragile X syndrome: A systematic review and meta-analysis. American Journal of Medical Genetics. Part A, 164A(7), 1648–1658.PubMedCrossRef
go back to reference Jiang, Y. H., Yuen, R. K., Jin, X., Wang, M., Chen, N., Wu, X., Ju, J., Mei, J., Shi, Y., He, M., & Wang, G. (2013). Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. The American Journal of Human Genetics, 93(2), 249–263.PubMedCrossRef Jiang, Y. H., Yuen, R. K., Jin, X., Wang, M., Chen, N., Wu, X., Ju, J., Mei, J., Shi, Y., He, M., & Wang, G. (2013). Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. The American Journal of Human Genetics, 93(2), 249–263.PubMedCrossRef
go back to reference Kim, M. J., Kim, D. J., Kim, S. Y., Yang, J. H., Kim, M. H., Lee, S. W., et al. (2013). Fragile X carrier screening in Korean women of reproductive age. Journal of Medical Screening, 20(1), 15–20.PubMedCrossRef Kim, M. J., Kim, D. J., Kim, S. Y., Yang, J. H., Kim, M. H., Lee, S. W., et al. (2013). Fragile X carrier screening in Korean women of reproductive age. Journal of Medical Screening, 20(1), 15–20.PubMedCrossRef
go back to reference Krishnan, A., Zhang, R., Yao, V., Theesfeld, C. L., Wong, A. K., Tadych, A., et al. (2016). Genome-wide prediction and functional characterization of the genetic basis of autism spectrum disorder. Nature Neuroscience, 19(11), 1454–1462.PubMedPubMedCentralCrossRef Krishnan, A., Zhang, R., Yao, V., Theesfeld, C. L., Wong, A. K., Tadych, A., et al. (2016). Genome-wide prediction and functional characterization of the genetic basis of autism spectrum disorder. Nature Neuroscience, 19(11), 1454–1462.PubMedPubMedCentralCrossRef
go back to reference Lee, M., Martin, G. E., Berry-Kravis, E., & Losh, M. (2016). A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome. Journal of Neurodevelopmental Disorders, 8, 47.PubMedPubMedCentralCrossRef Lee, M., Martin, G. E., Berry-Kravis, E., & Losh, M. (2016). A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome. Journal of Neurodevelopmental Disorders, 8, 47.PubMedPubMedCentralCrossRef
go back to reference Maenner, M. J., Baker, M. W., Broman, K. W., Tian, J., Barnes, J. K., Atkins, A., et al. (2013). FMR1 CGG expansions: Prevalence and sex ratios. American Journal of Medical Genetics Part B, 162B(5), 466–473.CrossRef Maenner, M. J., Baker, M. W., Broman, K. W., Tian, J., Barnes, J. K., Atkins, A., et al. (2013). FMR1 CGG expansions: Prevalence and sex ratios. American Journal of Medical Genetics Part B, 162B(5), 466–473.CrossRef
go back to reference Martin, G. E., Roberts, J. E., Helm-Estabrooks, N., Sideris, J., Vanderbilt, J., & Moskowitz, L. (2012). Perseveration in the connected speech of boys with Fragile X syndrome with and without autism spectrum disorder. American Journal on Intellectual and Developmental Disabilities, 117(5), 384–399.PubMedPubMedCentralCrossRef Martin, G. E., Roberts, J. E., Helm-Estabrooks, N., Sideris, J., Vanderbilt, J., & Moskowitz, L. (2012). Perseveration in the connected speech of boys with Fragile X syndrome with and without autism spectrum disorder. American Journal on Intellectual and Developmental Disabilities, 117(5), 384–399.PubMedPubMedCentralCrossRef
go back to reference Milà, M., Kruyer, H., Glover, G., Sánchez, A., Carbonell, P., Castellví-Bell, S., et al. (1994). Molecular analysis of the (CGG)n expansion in the FMR-1 gene in 59 Spanish fragile X syndrome families. Human Genetics, 94(4), 395–400.PubMedCrossRef Milà, M., Kruyer, H., Glover, G., Sánchez, A., Carbonell, P., Castellví-Bell, S., et al. (1994). Molecular analysis of the (CGG)n expansion in the FMR-1 gene in 59 Spanish fragile X syndrome families. Human Genetics, 94(4), 395–400.PubMedCrossRef
go back to reference Myrick, L. K., Nakamoto-Kinoshita, M., Lindor, N. M., Kirmani, S., Cheng, X., & Warren, S. T. (2014). Fragile X syndrome due to a missense mutation. European Journal of Human Genetics, 22(10), 1185–1189.PubMedPubMedCentralCrossRef Myrick, L. K., Nakamoto-Kinoshita, M., Lindor, N. M., Kirmani, S., Cheng, X., & Warren, S. T. (2014). Fragile X syndrome due to a missense mutation. European Journal of Human Genetics, 22(10), 1185–1189.PubMedPubMedCentralCrossRef
go back to reference Nussbaum, R., McInnes, R., & Willard, H. (2016). Patterns of single gene inheritance. Thompson & Thompson genetics in medicine (8th ed.). Elsevier. Nussbaum, R., McInnes, R., & Willard, H. (2016). Patterns of single gene inheritance. Thompson & Thompson genetics in medicine (8th ed.). Elsevier.
go back to reference Otsuka, S., Sakamoto, Y., Siomi, H., Itakura, M., Yamamoto, K., Matumoto, H., et al. (2010). Fragile X carrier screening and FMR1 allele distribution in the Japanese population. Brain & Development, 32(2), 110–114.CrossRef Otsuka, S., Sakamoto, Y., Siomi, H., Itakura, M., Yamamoto, K., Matumoto, H., et al. (2010). Fragile X carrier screening and FMR1 allele distribution in the Japanese population. Brain & Development, 32(2), 110–114.CrossRef
go back to reference Pembrey, M. E., Barnicoat, A. J., Carmichael, B., Bobrow, M., & Turner, G. (2001). An assessment of screening strategies for fragile X syndrome in the UK. Health Technology Assessment, 5(7), 1–95.PubMedCrossRef Pembrey, M. E., Barnicoat, A. J., Carmichael, B., Bobrow, M., & Turner, G. (2001). An assessment of screening strategies for fragile X syndrome in the UK. Health Technology Assessment, 5(7), 1–95.PubMedCrossRef
go back to reference Reddy, K. S. (2005). Cytogenetic abnormalities and fragile-X syndrome in autism spectrum disorder. BMC Medical Genetics, 18(6), 3.CrossRef Reddy, K. S. (2005). Cytogenetic abnormalities and fragile-X syndrome in autism spectrum disorder. BMC Medical Genetics, 18(6), 3.CrossRef
go back to reference Saldarriaga-Gil, W., Cabal-Herrera, A. M., Fandiño-Losada, A., Vásquez, A., Hagerman, R., & Tassone, F. (2021). Inequities in diagnosis of Fragile X syndrome in Colombia. Journal of Applied Research in Intellectual Disabilities, 34(3), 830–839.PubMedCrossRef Saldarriaga-Gil, W., Cabal-Herrera, A. M., Fandiño-Losada, A., Vásquez, A., Hagerman, R., & Tassone, F. (2021). Inequities in diagnosis of Fragile X syndrome in Colombia. Journal of Applied Research in Intellectual Disabilities, 34(3), 830–839.PubMedCrossRef
go back to reference Sihombing, N. R. B., Winarni, T. I., Utari, A., van Bokhoven, H., Hagerman, R. J., & Faradz, S. M. (2021). Surveillance and prevalence of fragile X syndrome in Indonesia. Intractable Rare Dis Res., 10(1), 11–16.PubMedPubMedCentralCrossRef Sihombing, N. R. B., Winarni, T. I., Utari, A., van Bokhoven, H., Hagerman, R. J., & Faradz, S. M. (2021). Surveillance and prevalence of fragile X syndrome in Indonesia. Intractable Rare Dis Res., 10(1), 11–16.PubMedPubMedCentralCrossRef
go back to reference Snow, K., Doud, L., Hagerman, R., Pergolizzi, R., Erster, S., & Thibodeau, S. (1993). Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. American Journal of Human Genetics, 53(6), 1217–1228.PubMedPubMedCentral Snow, K., Doud, L., Hagerman, R., Pergolizzi, R., Erster, S., & Thibodeau, S. (1993). Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. American Journal of Human Genetics, 53(6), 1217–1228.PubMedPubMedCentral
go back to reference Tanchanco, L. (2014). Validity and reliability of filipino version of the modified checklist for autism toddlers (M-CHAT:FV). University of the Philippines. Tanchanco, L. (2014). Validity and reliability of filipino version of the modified checklist for autism toddlers (M-CHAT:FV). University of the Philippines.
go back to reference Tassanakijpanich, N., Hagerman, R. J., & Worachotekamjorn, J. (2021). Fragile X premutation and associated health conditions: A review. Clinical Genetics, 99(6), 751–760.PubMedCrossRef Tassanakijpanich, N., Hagerman, R. J., & Worachotekamjorn, J. (2021). Fragile X premutation and associated health conditions: A review. Clinical Genetics, 99(6), 751–760.PubMedCrossRef
go back to reference Tassone, F. (2015). Advanced technologies for the molecular diagnosis of fragile X syndrome. Expert Review of Molecular Diagnostics, 15(11), 1465–1473.PubMedPubMedCentralCrossRef Tassone, F. (2015). Advanced technologies for the molecular diagnosis of fragile X syndrome. Expert Review of Molecular Diagnostics, 15(11), 1465–1473.PubMedPubMedCentralCrossRef
go back to reference Tassone, F., Iong, K. P., Tong, T. H., Lo, J., Gane, L. W., Berry-Kravis, E., et al. (2012). FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Medicine, 4(12), 100.PubMedPubMedCentralCrossRef Tassone, F., Iong, K. P., Tong, T. H., Lo, J., Gane, L. W., Berry-Kravis, E., et al. (2012). FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Medicine, 4(12), 100.PubMedPubMedCentralCrossRef
go back to reference Tassone, F., & Milà, M. (2017). Chapter 3: Molecular diagnostics and genetic counseling in fragile X syndrome and FMR1-associated disorders. In R. Willemsen & R. F. Kooy (Eds.), Fragile X syndrome (pp. 41–55). Academic Press.CrossRef Tassone, F., & Milà, M. (2017). Chapter 3: Molecular diagnostics and genetic counseling in fragile X syndrome and FMR1-associated disorders. In R. Willemsen & R. F. Kooy (Eds.), Fragile X syndrome (pp. 41–55). Academic Press.CrossRef
go back to reference Tassone, F., Pan, R., Amiri, K., Taylor, A. K., & Hagerman, P. J. (2008). A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. The Journal of Molecular Diagnostics, 10(1), 43–49.PubMedPubMedCentralCrossRef Tassone, F., Pan, R., Amiri, K., Taylor, A. K., & Hagerman, P. J. (2008). A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. The Journal of Molecular Diagnostics, 10(1), 43–49.PubMedPubMedCentralCrossRef
go back to reference Thurman, A. J., McDuffie, A., Hagerman, R. J., Josol, C. K., & Abbeduto, L. (2017). Language skills of males with fragile X syndrome or nonsyndromic autism spectrum disorder. Journal of Autism and Developmental Disorders, 47(3), 728–743.PubMedPubMedCentralCrossRef Thurman, A. J., McDuffie, A., Hagerman, R. J., Josol, C. K., & Abbeduto, L. (2017). Language skills of males with fragile X syndrome or nonsyndromic autism spectrum disorder. Journal of Autism and Developmental Disorders, 47(3), 728–743.PubMedPubMedCentralCrossRef
go back to reference Turner, G., Robinson, H., Laing, S., Goddard, A., van den Berk, M., Sherman, S., et al. (1992). Population screening for fragile X. The Lancet, 339(8803), 1210–1213.CrossRef Turner, G., Robinson, H., Laing, S., Goddard, A., van den Berk, M., Sherman, S., et al. (1992). Population screening for fragile X. The Lancet, 339(8803), 1210–1213.CrossRef
go back to reference Wang, Y. C., Li, C., Lin, M. L., Lin, W. H., & Li, S. Y. (2000). Molecular diagnosis of fragile X syndrome and distribution of CGG repeats in the FMR-1 gene in Taiwanese. Journal of the Formosan Medical Association = Taiwan Yi Zhi, 99(5), 402–407.PubMed Wang, Y. C., Li, C., Lin, M. L., Lin, W. H., & Li, S. Y. (2000). Molecular diagnosis of fragile X syndrome and distribution of CGG repeats in the FMR-1 gene in Taiwanese. Journal of the Formosan Medical Association = Taiwan Yi Zhi, 99(5), 402–407.PubMed
go back to reference Winarni, T. I., Utari, A., Mundhofir, F. E. P., Hagerman, R. J., & Faradz, S. M. H. (2013). Fragile X syndrome: Clinical, cytogenetic and molecular screening among autism spectrum disorder children in Indonesia. Clinical Genetics, 84(6), 577–580.PubMedCrossRef Winarni, T. I., Utari, A., Mundhofir, F. E. P., Hagerman, R. J., & Faradz, S. M. H. (2013). Fragile X syndrome: Clinical, cytogenetic and molecular screening among autism spectrum disorder children in Indonesia. Clinical Genetics, 84(6), 577–580.PubMedCrossRef
go back to reference Wolff, J. J., Bodfish, J. W., Hazlett, H. C., Lightbody, A. A., Reiss, A. L., & Piven, J. (2012). Evidence of a distinct behavioral phenotype in young boys with fragile X syndrome and autism. Journal of the American Academy of Child and Adolescent Psychiatry, 51(12), 1324–1332.PubMedPubMedCentralCrossRef Wolff, J. J., Bodfish, J. W., Hazlett, H. C., Lightbody, A. A., Reiss, A. L., & Piven, J. (2012). Evidence of a distinct behavioral phenotype in young boys with fragile X syndrome and autism. Journal of the American Academy of Child and Adolescent Psychiatry, 51(12), 1324–1332.PubMedPubMedCentralCrossRef
go back to reference Yang, Y., Tian, J., & Yang, B. (2018). Targeting gut microbiome: A novel and potential therapy for autism. Life Sciences, 194, 111–119.PubMedCrossRef Yang, Y., Tian, J., & Yang, B. (2018). Targeting gut microbiome: A novel and potential therapy for autism. Life Sciences, 194, 111–119.PubMedCrossRef
go back to reference Yoon, S. H., Choi, J., Lee, W. J., & Do, J. T. (2020). Genetic and epigenetic etiology underlying autism spectrum disorder. Journal of Clinical Medicine, 9(4), 966.PubMedPubMedCentralCrossRef Yoon, S. H., Choi, J., Lee, W. J., & Do, J. T. (2020). Genetic and epigenetic etiology underlying autism spectrum disorder. Journal of Clinical Medicine, 9(4), 966.PubMedPubMedCentralCrossRef
go back to reference Yrigollen, C. M., Durbin-Johnson, B., Gane, L., Nelson, D. L., Hagerman, R., Hagerman, P. J., et al. (2012). AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genetics in Medicine, 14(8), 729–736.PubMedPubMedCentralCrossRef Yrigollen, C. M., Durbin-Johnson, B., Gane, L., Nelson, D. L., Hagerman, R., Hagerman, P. J., et al. (2012). AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genetics in Medicine, 14(8), 729–736.PubMedPubMedCentralCrossRef
Metagegevens
Titel
Screening for Fragile X Syndrome Among Filipino Children with Autism Spectrum Disorder
Auteurs
Angel Belle C. Dy
Lourdes Bernadette S. Tanchanco
Jenica Clarisse Y. Sy
Myla Dominicina Levantino
Randi J. Hagerman
Publicatiedatum
16-08-2022
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 11/2023
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-022-05707-8

Andere artikelen Uitgave 11/2023

Journal of Autism and Developmental Disorders 11/2023 Naar de uitgave